Marex Group MRX
$58.73 −$2.69 (-4.38%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $58.79 +0.10%
Open$59.70
Prev close$61.42
Day range$55.10 – $59.70
Volume2.02M
Market cap$4.22B
P/E (TTM)9.9
Dividend yield1.06%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$743.20M+53.4% YoY
Operating profit$172.30M+82.1% YoY
Net profit$130.30M+78.0% YoY
Diluted EPS$1.45+57.6% YoY
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Annual revenue
Profitability & balance sheet
Gross margin47.0%
Operating margin33.1%
Net margin9.9%
Return on equity29.8%
Return on assets1.2%
Return on invested capital9.6%
Current ratio1.08
Liabilities / assets95.7%
Cash & investments$8.28B
Total debt$13.21B
Net cash (debt)-$4.94B
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $743.20M | $695.80M | $692.30M | $2.02B | $572.10M |
| Total Operating Revenue | $743.20M | $1.18B | $1.33B | $3.63B | $1.01B |
| Cost of Revenue | $429.20M | $623.60M | $845.50M | $1.92B | $397.10M |
| Gross Profit | $314.00M | $552.90M | $487.90M | $1.71B | $611.70M |
| Operating Expense | $141.70M | $136.00M | $125.40M | $534.50M | $261.40M |
| Depreciation & Amortization & Depletion | $11.60M | $11.40M | $11.70M | $36.10M | $10.00M |
| -Depreciation & Amortization | $11.60M | $11.40M | $11.70M | $36.10M | $10.00M |
| Asset Impairment Loss | $6.70M | $1.80M | $7.00M | -$700,000.00 | -$1.90M |
| Other Operating Expenses | $123.40M | $122.80M | $106.70M | $204.10M | -$41.70M |
| Operating Profit | $172.30M | $416.90M | $362.50M | $1.17B | $350.30M |
| Other Income (Expense) | $400,000.00 | $2.50M | $3.70M | $11.00M | -$100,000.00 |
| Special Income (Charges) | $0.00 | $0.00 | $0.00 | $3.60M | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | $0.00 | $0.00 | -$3.60M | $0.00 |
| Other Non-Operating Income (Expenses) | $400,000.00 | $2.50M | $3.70M | $7.40M | -$100,000.00 |
| Pretax Profit | $172.70M | $158.20M | $149.80M | $411.60M | $111.20M |
| Tax | $42.40M | $38.30M | $37.50M | $103.70M | $25.70M |
| Net Profit | $130.30M | $155.30M | $112.40M | $307.70M | $85.30M |
| Profit from Continuing Operations | $130.30M | $119.90M | $112.30M | $307.90M | $85.50M |
| Net Income from Discontinuous Operations | $0.00 | $35.40M | $100,000.00 | -$200,000.00 | -$200,000.00 |
| Net Income to Parent Company | $130.30M | $155.60M | $112.40M | $307.20M | $84.80M |
| Net Income to Common Stockholders | $130.30M | $147.40M | $112.40M | $293.90M | $71.50M |
| Basic EPS | $1.52 | $2.09 | $1.52 | $4.12 | $1.19 |
| Diluted EPS | $1.45 | $2.00 | $1.43 | $3.86 | $1.19 |
| Dividend Per Share | $0.16 | $0.16 | $0.15 | $0.59 | $0.15 |
| Net Non-Operating Interest Income (Expense) | – | -$261.20M | -$216.40M | -$770.50M | -$239.00M |
| Non-Operating Interest Expense | – | $261.20M | $216.40M | $760.20M | $228.70M |
| Selling and Admin Expenses | – | – | – | $288.80M | – |
| -General & Admin Expense | – | – | – | $288.80M | – |
| Other Taxes | – | – | – | $6.20M | – |
| Total Other Finance Costs | – | – | – | $10.30M | – |
| Earnings from Equity Interest | – | – | – | $0.00 | – |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | – |
| Minority Interests | – | – | – | $500,000.00 | – |
| Other Preferred Stock Dividends | – | – | – | $13.30M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $45.40B | $42.13B | $36.53B | $34.68B | $34.68B |
| Total Current Assets | $43.92B | $40.60B | $35.42B | $33.70B | $33.70B |
| Cash and Cash Equivalents & Short-Term Investments | $8.28B | $8.45B | $6.89B | $6.48B | $6.48B |
| -Cash and Cash Equivalents | $3.21B | $3.85B | $3.07B | $2.88B | $2.88B |
| -Short Term Investments | $5.06B | $4.60B | $3.82B | $3.60B | $3.60B |
| Receivables | $15.58B | $12.84B | $13.95B | $14.14B | $14.14B |
| -Accounts Receivable | $12.67B | $9.84B | $10.68B | $10.99B | $10.99B |
| -Loans Receivable | $2.86B | $2.96B | $3.25B | $3.12B | $3.12B |
| -Taxes Receivable | $47.90M | $27.60M | $12.80M | $27.60M | $27.60M |
| Inventory | $473.30M | $534.80M | $300.10M | $483.70M | $483.70M |
| Restricted Cash | $14.37B | $15.89B | $10.84B | $9.92B | $9.92B |
| Total Non-Current Assets | $1.49B | $1.52B | $1.11B | $978.20M | $978.20M |
| Net PPE | $122.30M | $115.70M | $109.10M | $110.90M | $110.90M |
| -Gross PPE | $122.30M | $115.70M | $109.10M | $160.90M | $160.90M |
| Investments and Advances | $87.30M | $103.50M | $220.80M | $111.60M | $111.60M |
| -Available for Sale Securities | $50.30M | $103.50M | $220.80M | $101.10M | $101.10M |
| Financial Assets | $0.00 | $6.50M | $6.50M | $19.60M | $19.60M |
| Non Current Accounts Receivables | $64.30M | $63.90M | $50.80M | $50.20M | $50.20M |
| Goodwill and Other Intangible Assets | $390.80M | $354.30M | $331.90M | $335.40M | $335.40M |
| -Goodwill | $301.30M | $261.80M | $237.20M | $237.40M | $237.40M |
| -Other Intangible Assets | $89.50M | $92.50M | $94.70M | $98.00M | $98.00M |
| Non-Current Deferred Assets | $65.10M | $48.50M | $33.40M | $30.60M | $30.60M |
| Other Non-Current Assets | $758.50M | $829.00M | $353.10M | $319.90M | $319.90M |
| Total Liabilities | $43.44B | $40.26B | $35.18B | $33.41B | $33.41B |
| Total Current Liabilities | $40.65B | $37.33B | $32.78B | $30.96B | $30.96B |
| Payables | $13.86B | $12.17B | $14.78B | $12.33B | $12.33B |
| -Accounts Payable | $13.79B | $11.16B | $14.77B | $11.78B | $11.78B |
| -Total Tax Payable | $70.30M | $67.30M | $12.00M | $31.00M | $31.00M |
| Short-Term Debt and Capital Lease Obligation | $10.58B | $8.68B | $8.00B | $7.82B | $7.82B |
| -Current Debt | $10.56B | $8.67B | $7.99B | $7.81B | $7.81B |
| -Current Capital Lease Obligation | $14.20M | $12.90M | $10.70M | $9.90M | $9.90M |
| Current Provisions | $9.40M | $6.60M | $5.00M | $3.80M | $3.80M |
| Other Current Liabilities | $16.20B | $15.84B | $10.00B | $10.24B | $10.24B |
| Total Non-Current Liabilities | $2.79B | $2.92B | $2.41B | $2.45B | $2.45B |
| Long Term Debt and Capital Lease Obligation | $2.65B | $2.85B | $2.36B | $2.41B | $2.41B |
| -Long Term Debt | $2.56B | $2.76B | $2.28B | $2.33B | $2.33B |
| -Long Term Capital Lease Obligation | $87.00M | $88.70M | $84.10M | $87.40M | $87.40M |
| Derivative Product Liabilities | $130.90M | $59.60M | $29.70M | $19.40M | $19.40M |
| Non-Current Deferred Liabilities | $9.90M | $12.90M | $13.20M | $14.00M | $14.00M |
| Total Equity | $1.97B | $1.87B | $1.35B | $1.26B | $1.26B |
| Stockholders' Equity | $1.97B | $1.87B | $1.35B | $1.26B | $1.26B |
| Capital Stock | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| -Common Stock | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| Additional Paid-In Capital | $273.70M | $232.40M | $324.80M | $324.80M | $324.80M |
| Retained Earnings | $1.33B | $1.20B | $1.08B | $982.00M | $982.00M |
| Less: Treasury Stock | -$103.20M | -$57.30M | -$52.90M | -$58.50M | -$58.50M |
| Gains/Losses Not Affecting Retained Earnings | -$23.70M | -$2.70M | -$4.90M | $15.40M | $15.40M |
| Other Equity Interests | $494.80M | $495.30M | – | – | – |
| Minority Interests | -$2.20M | -$2.00M | -$2.30M | -$200,000.00 | -$200,000.00 |
| -Other Payable | – | $940.70M | – | $516.80M | $516.80M |
| Current Accrued Expenses | – | $643.60M | – | $568.20M | $568.20M |
| -Accumulated Depreciation | – | – | – | -$50.00M | -$50.00M |
| -Trading Securities | – | – | – | $10.50M | $10.50M |
Cash flow
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Operating Cash Flow | $667.50M | $1.16B | $735.00M | $225.60M | $470.80M |
| Net cash flow from continuing operations | $667.50M | $1.16B | $735.00M | $225.60M | $470.80M |
| Net Income from Continuing Operations | $411.60M | $295.80M | $196.50M | $121.60M | $69.90M |
| Gain/Loss from Continuing Operations | $469.30M | -$188.10M | -$67.70M | $110.70M | $221.50M |
| Depreciation & Depletion & Amortization | $36.10M | $28.80M | $21.90M | $13.80M | $10.30M |
| Other Non-Cash Items | -$53.30M | $16.80M | -$6.90M | -$62.30M | $2.90M |
| Change in Working Capital | -$98.10M | $1.04B | $609.00M | -$22.00M | $184.10M |
| -Change in Receivables | -$2.57B | -$2.76B | $777.60M | $3.14B | -$1.57B |
| -Change in Inventory | -$422.00M | $127.60M | -$127.60M | $44.30M | -$71.40M |
| -Change in Payables and Accrued Expense | $2.26B | $2.95B | -$709.50M | -$2.87B | $1.12B |
| -Change in Other Current Assets | -$462.80M | -$674.10M | -$262.60M | -$494.00M | -$29.80M |
| -Change in Other Current Liabilities | $1.10B | $1.39B | $931.10M | $160.40M | $733.80M |
| Net cash flow from investing | -$264.30M | -$35.30M | -$97.60M | -$46.30M | -$19.80M |
| Net Cash Flow from Continuing Investing Activities | -$264.30M | -$35.30M | -$97.60M | -$46.30M | -$19.80M |
| Net PPE Purchase and Sale | -$13.10M | -$11.70M | -$9.00M | -$3.60M | -$3.80M |
| Net Intangibles Purchase and Sale | -$6.70M | -$8.20M | -$3.10M | -$5.80M | -$3.50M |
| Net Business Purchase and Sale | -$241.60M | -$11.00M | -$85.50M | -$36.90M | -$12.50M |
| Net Investment Purchase and Sale | -$2.90M | -$4.40M | $0.00 | $0.00 | – |
| Financing Cash Flow | -$123.90M | -$37.20M | -$72.80M | $26.50M | -$27.20M |
| Net Cash Flow from Continuing Financing Activities | -$123.90M | -$37.20M | -$72.80M | $26.50M | -$27.20M |
| Net Issuance Payments Of Debt | -$24.30M | -$8.60M | -$11.40M | -$56.60M | -$7.20M |
| Net Common Stock Issuance | -$44.10M | $53.30M | -$3.10M | -$7.90M | $0.00 |
| Cash Dividends Paid | -$55.50M | -$77.10M | -$58.30M | -$6.60M | -$20.00M |
| Ending Cash Balance | $2.88B | $2.56B | $1.48B | $910.10M | $712.00M |
| Net Change in Cash | $279.30M | $1.09B | $564.60M | $205.80M | $423.80M |
| Beginning Cash Balance | $2.56B | $1.48B | $910.10M | $712.00M | $291.50M |
| Effect of Exchange Rate Changes | $58.80M | -$17.90M | $8.80M | -$7.70M | -$3.30M |
| Free Cash Flow | $647.70M | $1.14B | $722.90M | $216.20M | $463.50M |
| Net Other Financing Charges | – | -$4.80M | – | $97.60M | – |
| -Change In Other Working Capital | – | – | – | – | $600,000.00 |
No comments yet — be the first to weigh in on MRX.
Sign in to join the discussion.